drugset / Trial / NCT00874484

Enoxaparin as Treatment for Vulvodynia

NCT00874484

Phase 2 Completed 40 enrolled Western Galilee Hospital-Nahariya
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators hypothesize that injections of Low molecular weight heparin (LMWH) \[enoxaparin\] will reduce pain in women with vulvodynia.

Timeline

Start
2009-03
Primary completion
2011-04
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoxaparin sodium Other / unclassified 40 mg Subcutaneous

Indications